Health Care Equipment & Services

Inside PACS Group’s disciplined 10b‑5 selling: Jergensen Joshua’s recent 36k‑share block highlights confidence in a high‑growth healthcare imaging stock, yet signals a potential buying window for savvy investors.

Explore how Clover Health’s sell‑to‑cover trade of 3,170 shares reveals RSU vesting trends and what it means for investors in a volatile market.

Guardant Health insider sell‑offs rise; analyst says moves are routine vesting, not a sign of trouble, amid strong stock gains.

Medtronic insider sale of 1,483 shares by EVP Harry Skip hints at a potential earnings beat after FDA clearance of LigaSure RAS, driving investor buzz.

Beta Bionics insider sale by CPO Mike Mensinger: a planned 10b5‑1 move amid bullish momentum, keeping leadership stakes high while watching future pipeline milestones.

Investor insights: Cencora insider Greenberg sells 1,280 shares—routine, low‑impact move reflecting portfolio management, not a warning to investors.

Evans Tyler Matthew’s modest 982‑share sale of NAKAMOTO Inc. reflects routine tax‑withholding, while continued insider buying signals long‑term confidence in its health‑tech and blockchain pivot.

CEO John Kao’s recent big sell‑off at Alignment Healthcare sparks investor concerns: why he’s off‑loading shares amid a steep stock decline and what it means for future upside.

Centene insider sale: CEO Pienkos sells 1,092 shares after a record high—analyzing the impact on investor confidence and company growth.

Health Catalyst CEO buys nearly 2.8 million shares, signaling strong confidence in the company’s AI‑driven health‑tech future.